Nerve-sparing robotic prostatectomy in preoperatively high-risk patients is safe and efficacious

Urologic Oncology: Seminars and Original Investigations

Volumn 30, Issue 1, 2012, Pages 26-32

  Lavery, Hugh J ^a   Nabizada Pace, Fatima ^a   Carlucci, John R ^a   Brajtbord, Jonathan S ^a   Samadi, David B ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Neoplasm; Prostate; Prostatectomy; Robotics

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BIOPSY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; NERVE SPARING ROBOTIC PROSTATECTOMY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; ROBOTICS; SAFETY; SEMINAL VESICLE; TREATMENT OUTCOME;

HUMANS; MALE; NEOPLASM GRADING; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; RISK FACTORS; ROBOTICS;

EID: 84855684198     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.11.023     Document Type: Article

References (28)

1. Bastian P.J., Gonzalgo M.L., Aronson W.J., et al. Clinical and pathologic outcome after radical prostatectomy for prostate cancer patients with a preoperative Gleason sum of 8 to 10. Cancer 2006, 107:1265-1272.
2. Stephenson A.J., Kattan M.W., Eastham J.A., et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 2009, 27:4300-4305.
3. Quinlan D.M., Epstein J.I., Carter B.S., et al. Sexual function following radical prostatectomy: Influence of preservation of neurovascular bundles. J Urol 1991, 145:998-1002.
4. Eastham J.A., Kattan M.W., Rogers E., et al. Risk factors for urinary incontinence after radical prostatectomy. J Urol 1996, 156:1707-1713.
5. Zorn K.C., Gofrit O.N., Steinberg G.P., et al. Planned nerve preservation to reduce positive surgical margins during robot-assisted laparoscopic radical prostatectomy. J Endourol 2008, 22:1303-1309.
6. Secin F.P., Serio A., Bianco F.J., et al. Preoperative and intraoperative risk factors for side-specific positive surgical margins in laparoscopic radical prostatectomy for prostate cancer. Eur Urol 2007, 51:764-771.
7. Graefen M., Haese A., Pichlmeier U., et al. A validated strategy for side specific prediction of organ confined prostate cancer: A tool to select for nerve-sparing radical prostatectomy. J Urol 2001, 165:857-863.
8. Steuber T., Graefen M., Haese A., et al. Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy. J Urol 2006, 175:939-944. Discussion 44.
9. Ohori M., Kattan M.W., Koh H., et al. Predicting the presence and side of extracapsular extension: A nomogram for staging prostate cancer. J Urol 2004, 171:1844-1849. Discussion 9.
10. Park E.L., Dalkin B., Escobar C., et al. Site-specific positive margins at radical prostatectomy: Assessing cancer-control benefits of wide excision of the neurovascular bundle on a side with cancer on biopsy. BJU Int 2003, 91:219-222.
11. Tsuzuki T., Hernandez D.J., Aydin H., et al. Prediction of extraprostatic extension in the neurovascular bundle based on prostate needle biopsy pathology, serum prostate specific antigen, and digital rectal examination. J Urol 2005, 173:450-453.
12. D'Amico A.V., Whittington R., Malkowicz S.B., et al. Pretreatment nomogram for prostate-specific antigen recurrence after radical prostatectomy or external-beam radiation therapy for clinically localized prostate cancer. J Clin Oncol 1999, 17:168-172.
13. Marks R.A., Lin H., Koch M.O., et al. Positive-block ratio in radical prostatectomy specimens is an independent predictor of prostate-specific antigen recurrence. Am J Surg Pathol 2007, 31:877-881.
14. Shikanov S., Song J., Royce C., et al. Length of positive surgical margin after radical prostatectomy as a predictor of biochemical recurrence. J Urol 2009, 182:139-144.
15. Rapp D.E., Orvieto M.A., Lucioni A., et al. Intraoperative prostate examination: Predictive value and effect on margin status. BJU Int 2005, 96:1005-1008.
16. Shikanov S.A., Thong A., Gofrit O.N., et al. Robotic laparoscopic radical prostatectomy for biopsy Gleason 8 to 10: Prediction of favorable pathologic outcome with preoperative parameters. J Endourol 2008, 22:1477-1481.
17. Donohue J.F., Bianco F.J., Kuroiwa K., et al. Poorly differentiated prostate cancer treated with radical prostatectomy: Long-term outcome and incidence of pathological downgrading. J Urol 2006, 176:991-995.
18. Manoharan M., Bird V.G., Kim S.S., et al. Outcome after radical prostatectomy with a pretreatment prostate biopsy Gleason score of ≥8. BJU Int 2003, 92:539-544.
19. Brandli D.W., Koch M.O., Foster R.S., et al. Biochemical disease-free survival in patients with a high prostate-specific antigen level (20-100 ng/ml) and clinically localized prostate cancer after radical prostatectomy. BJU Int 2003, 92:19-22. Discussion 23.
20. Nguyen K., Eltz S., Drouin S.J., et al. Oncologic outcome after radical prostatectomy in men with PSA values above 20 ng/ml: A monocentric experience. World J Urol 2009, 27:653-658.
21. Ochiai A., Sotelo T., Troncoso P., et al. Natural history of biochemical progression after radical prostatectomy based on length of a positive margin. Urology 2008, 71:308-312.
22. Yossepowitch O., Eggener S.E., Serio A.M., et al. Secondary therapy, metastatic progression, and cancer-specific mortality in men with clinically high-risk prostate cancer treated with radical prostatectomy. Eur Urol 2008, 53:950-959.
23. Ficarra V., Novara G., Artibani W., et al. Retropubic, laparoscopic, and robot-assisted radical prostatectomy: A systematic review and cumulative analysis of comparative studies. Eur Urol 2009, 55:1037-1063.
24. Upton G.J.G., Cook I. A dictionary of statistics 2008, Oxford University Press, Oxford (UK). 2nd ed.
25. D'Amico A.V., Chen M.H., Renshaw A.A., et al. Androgen suppression and radiation vs. radiation alone for prostate cancer: A randomized trial. JAMA 2008, 299:289-295.
26. Novara G., Ficarra V., D'Elia C., et al. Preoperative criteria to select patients for bilateral nerve-sparing robotic-assisted radical prostatectomy. J Sex Med 2009, in press.
27. Stanford J.L., Feng Z., Hamilton A.S., et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: The Prostate Cancer Outcomes Study. JAMA 2000, 283:354-360.
28. Thompson I.M., Tangen C.M., Paradelo J., et al. Adjuvant radiotherapy for pathologic T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: Long-term follow-up of a randomized clinical trial. J Urol 2009, 181:956-962.